Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.

[1]  M. Triggiani,et al.  Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group , 2014, Allergy.

[2]  H. Farkas,et al.  The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency , 2014, Orphanet Journal of Rare Diseases.

[3]  H. Farkas.  Current pharmacotherapy of bradykinin-mediated angioedema , 2013, Expert opinion on pharmacotherapy.

[4]  D. Haverstick,et al.  Specimen Collection and Processing , 2012 .

[5]  G. Mazeto,et al.  Autoimmune thyroid disease as a risk factor for angioedema in patients with chronic idiopathic urticaria: a case-control study. , 2012, Sao Paulo medical journal = Revista paulista de medicina.

[6]  H. Farkas,et al.  Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency. , 2011, Clinical immunology.

[7]  A. Kaplan,et al.  The plasma bradykinin-forming pathways and its interrelationships with complement. , 2010, Molecular immunology.

[8]  H. Farkas,et al.  Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema. , 2010, Clinical immunology.

[9]  H. Farkas,et al.  The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study , 2010, European Journal of Clinical Pharmacology.

[10]  M. Cicardi,et al.  C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. , 2009, Trends in molecular medicine.

[11]  Bin Zhang,et al.  Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica. , 2008, Neuro endocrinology letters.

[12]  B. Zuraw.  Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  H. Farkas,et al.  Anti-cholesterol antibody levels in hereditary angioedema , 2007, Journal of cellular and molecular medicine.

[14]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[15]  S. Bahna,et al.  Resolution of chronic urticaria and angioedema with thyroxine. , 2005, Allergy and asthma proceedings.

[16]  C-S Wang,et al.  Plasma protein regulation by thyroid hormone. , 2003, The Journal of endocrinology.

[17]  M. Cicardi,et al.  Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol. , 2003, Immunology letters.

[18]  J. Negro,et al.  Facial edema associated with thyroid autoimmunity. , 2002, Allergologia et immunopathologia.

[19]  N. Shahidi.  A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. , 2001, Clinical therapeutics.

[20]  P. Giral,et al.  Relationship between thyroid hormones and fibrinogen levels. , 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[21]  M. Cicardi,et al.  Local bradykinin generation in hereditary angioedema. , 1999, The Journal of allergy and clinical immunology.

[22]  P. Giral,et al.  Relationship between Thyroid Hormones and Plasma D-dimer Levels , 1998, Thrombosis and Haemostasis.

[23]  P. Wise,et al.  Hereditary angioedema and thyroid autoimmunity. , 1987, Journal of clinical pathology.

[24]  G. Tsokos,et al.  Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities. , 1986, The Journal of allergy and clinical immunology.

[25]  G. Rannevik,et al.  Effect of danazol on thyroid function in postmenopausal women , 1984, Acta obstetricia et gynecologica Scandinavica. Supplement.

[26]  P. D. Bewsher,et al.  Coagulation and fibrinolysis in thyroid disease. , 1978, Acta haematologica.

[27]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[28]  E. Feldman,et al.  ENDOCRINOLOGIC AND METABOLIC EFFECTS OF 17α-METHYL-19-NORTESTOSTERONE IN WOMEN*† , 1960 .